Anticlastogenic activity of morin against whole body gamma irradiation in Swiss albino mice

Vipan Kumar Parihar, Koiram Rajanna Prabhakar, Veeresh Prabhakar Veerapur, Kavirayani Indira Priyadarsini, Mazhuvancherry Kesavan Unnikrishnan, Chamallamudi Mallikajuna Rao

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Anticlastogenic activity of morin was explored against whole body gamma radiation, at a dose rate of 1.66 Gy/min in Swiss albino mice pretreated intraperitoneal or orally. Pretreatment with morin 10, 25, 50, 75, 100, 125, and 150 mg/kg, i.p. delayed and reduced percentage mortality and increased mean survival times in mice irradiated with 10 Gy gamma radiation. Intraperitoneal route was found superior to oral route. An i.p. dose of 100 mg/kg was found to be the most effective dose in preventing radiation-induced weight loss, increasing the mean survival times and reducing percentage mortality. Morin (100 mg/kg) pretreatment effectively maintained spleen index (spleen weight / body weight × 100) and stimulated endogenous spleen colony forming units. Pretreatment with morin (100 mg/kg) significantly reduced dead, inflammatory, and mitotic cells in irradiated mice jejunum along with a significant increase in goblet cells and rapidly multiplying crypt cells. Morin (100 mg/kg) also maintained the villus height close to normal, prevented mucosal erosion and basement membrane damage in irradiated jejunum. Nuclear enlargement in epithelial cells of jejunum was lower in morin treated mice compared to radiation control. Morin (100 mg/kg) also significantly elevated the endogenous antioxidant enzymes viz. glutathione S transferase (GST), superoxide dismutase (SOD) and reduced glutathione (GSH), in normal mice at 2, 4 and 8 h post treatment. Drastic decrease in endogenous enzymes (GSH, GST, catalase and SOD) and total thiols was observed in irradiated mice at 2, 4 and 8 h post irradiation, while pretreatment with morin (100 mg/kg) prevented this decrease. Morin (100 mg/kg) also elevated radiation LD50 from 9.2 to 10.1 Gy, indicating a dose modifying factor (DMF) of 1.11.

Original languageEnglish
Pages (from-to)58-65
Number of pages8
JournalEuropean Journal of Pharmacology
Volume557
Issue number1
DOIs
Publication statusPublished - 14-02-2007

Fingerprint

Whole-Body Irradiation
Jejunum
Spleen
Gamma Rays
Radiation
Glutathione Transferase
Superoxide Dismutase
Survival Rate
morin
Goblet Cells
Mortality
Lethal Dose 50
Enzymes
Sulfhydryl Compounds
Basement Membrane
Catalase
Glutathione
Weight Loss
Stem Cells
Antioxidants

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Parihar, Vipan Kumar ; Prabhakar, Koiram Rajanna ; Veerapur, Veeresh Prabhakar ; Priyadarsini, Kavirayani Indira ; Unnikrishnan, Mazhuvancherry Kesavan ; Rao, Chamallamudi Mallikajuna. / Anticlastogenic activity of morin against whole body gamma irradiation in Swiss albino mice. In: European Journal of Pharmacology. 2007 ; Vol. 557, No. 1. pp. 58-65.
@article{c2c621c86ece4e08aed46a0b7c041bd8,
title = "Anticlastogenic activity of morin against whole body gamma irradiation in Swiss albino mice",
abstract = "Anticlastogenic activity of morin was explored against whole body gamma radiation, at a dose rate of 1.66 Gy/min in Swiss albino mice pretreated intraperitoneal or orally. Pretreatment with morin 10, 25, 50, 75, 100, 125, and 150 mg/kg, i.p. delayed and reduced percentage mortality and increased mean survival times in mice irradiated with 10 Gy gamma radiation. Intraperitoneal route was found superior to oral route. An i.p. dose of 100 mg/kg was found to be the most effective dose in preventing radiation-induced weight loss, increasing the mean survival times and reducing percentage mortality. Morin (100 mg/kg) pretreatment effectively maintained spleen index (spleen weight / body weight × 100) and stimulated endogenous spleen colony forming units. Pretreatment with morin (100 mg/kg) significantly reduced dead, inflammatory, and mitotic cells in irradiated mice jejunum along with a significant increase in goblet cells and rapidly multiplying crypt cells. Morin (100 mg/kg) also maintained the villus height close to normal, prevented mucosal erosion and basement membrane damage in irradiated jejunum. Nuclear enlargement in epithelial cells of jejunum was lower in morin treated mice compared to radiation control. Morin (100 mg/kg) also significantly elevated the endogenous antioxidant enzymes viz. glutathione S transferase (GST), superoxide dismutase (SOD) and reduced glutathione (GSH), in normal mice at 2, 4 and 8 h post treatment. Drastic decrease in endogenous enzymes (GSH, GST, catalase and SOD) and total thiols was observed in irradiated mice at 2, 4 and 8 h post irradiation, while pretreatment with morin (100 mg/kg) prevented this decrease. Morin (100 mg/kg) also elevated radiation LD50 from 9.2 to 10.1 Gy, indicating a dose modifying factor (DMF) of 1.11.",
author = "Parihar, {Vipan Kumar} and Prabhakar, {Koiram Rajanna} and Veerapur, {Veeresh Prabhakar} and Priyadarsini, {Kavirayani Indira} and Unnikrishnan, {Mazhuvancherry Kesavan} and Rao, {Chamallamudi Mallikajuna}",
year = "2007",
month = "2",
day = "14",
doi = "10.1016/j.ejphar.2006.09.073",
language = "English",
volume = "557",
pages = "58--65",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

Anticlastogenic activity of morin against whole body gamma irradiation in Swiss albino mice. / Parihar, Vipan Kumar; Prabhakar, Koiram Rajanna; Veerapur, Veeresh Prabhakar; Priyadarsini, Kavirayani Indira; Unnikrishnan, Mazhuvancherry Kesavan; Rao, Chamallamudi Mallikajuna.

In: European Journal of Pharmacology, Vol. 557, No. 1, 14.02.2007, p. 58-65.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Anticlastogenic activity of morin against whole body gamma irradiation in Swiss albino mice

AU - Parihar, Vipan Kumar

AU - Prabhakar, Koiram Rajanna

AU - Veerapur, Veeresh Prabhakar

AU - Priyadarsini, Kavirayani Indira

AU - Unnikrishnan, Mazhuvancherry Kesavan

AU - Rao, Chamallamudi Mallikajuna

PY - 2007/2/14

Y1 - 2007/2/14

N2 - Anticlastogenic activity of morin was explored against whole body gamma radiation, at a dose rate of 1.66 Gy/min in Swiss albino mice pretreated intraperitoneal or orally. Pretreatment with morin 10, 25, 50, 75, 100, 125, and 150 mg/kg, i.p. delayed and reduced percentage mortality and increased mean survival times in mice irradiated with 10 Gy gamma radiation. Intraperitoneal route was found superior to oral route. An i.p. dose of 100 mg/kg was found to be the most effective dose in preventing radiation-induced weight loss, increasing the mean survival times and reducing percentage mortality. Morin (100 mg/kg) pretreatment effectively maintained spleen index (spleen weight / body weight × 100) and stimulated endogenous spleen colony forming units. Pretreatment with morin (100 mg/kg) significantly reduced dead, inflammatory, and mitotic cells in irradiated mice jejunum along with a significant increase in goblet cells and rapidly multiplying crypt cells. Morin (100 mg/kg) also maintained the villus height close to normal, prevented mucosal erosion and basement membrane damage in irradiated jejunum. Nuclear enlargement in epithelial cells of jejunum was lower in morin treated mice compared to radiation control. Morin (100 mg/kg) also significantly elevated the endogenous antioxidant enzymes viz. glutathione S transferase (GST), superoxide dismutase (SOD) and reduced glutathione (GSH), in normal mice at 2, 4 and 8 h post treatment. Drastic decrease in endogenous enzymes (GSH, GST, catalase and SOD) and total thiols was observed in irradiated mice at 2, 4 and 8 h post irradiation, while pretreatment with morin (100 mg/kg) prevented this decrease. Morin (100 mg/kg) also elevated radiation LD50 from 9.2 to 10.1 Gy, indicating a dose modifying factor (DMF) of 1.11.

AB - Anticlastogenic activity of morin was explored against whole body gamma radiation, at a dose rate of 1.66 Gy/min in Swiss albino mice pretreated intraperitoneal or orally. Pretreatment with morin 10, 25, 50, 75, 100, 125, and 150 mg/kg, i.p. delayed and reduced percentage mortality and increased mean survival times in mice irradiated with 10 Gy gamma radiation. Intraperitoneal route was found superior to oral route. An i.p. dose of 100 mg/kg was found to be the most effective dose in preventing radiation-induced weight loss, increasing the mean survival times and reducing percentage mortality. Morin (100 mg/kg) pretreatment effectively maintained spleen index (spleen weight / body weight × 100) and stimulated endogenous spleen colony forming units. Pretreatment with morin (100 mg/kg) significantly reduced dead, inflammatory, and mitotic cells in irradiated mice jejunum along with a significant increase in goblet cells and rapidly multiplying crypt cells. Morin (100 mg/kg) also maintained the villus height close to normal, prevented mucosal erosion and basement membrane damage in irradiated jejunum. Nuclear enlargement in epithelial cells of jejunum was lower in morin treated mice compared to radiation control. Morin (100 mg/kg) also significantly elevated the endogenous antioxidant enzymes viz. glutathione S transferase (GST), superoxide dismutase (SOD) and reduced glutathione (GSH), in normal mice at 2, 4 and 8 h post treatment. Drastic decrease in endogenous enzymes (GSH, GST, catalase and SOD) and total thiols was observed in irradiated mice at 2, 4 and 8 h post irradiation, while pretreatment with morin (100 mg/kg) prevented this decrease. Morin (100 mg/kg) also elevated radiation LD50 from 9.2 to 10.1 Gy, indicating a dose modifying factor (DMF) of 1.11.

UR - http://www.scopus.com/inward/record.url?scp=33846350983&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846350983&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.09.073

DO - 10.1016/j.ejphar.2006.09.073

M3 - Article

VL - 557

SP - 58

EP - 65

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -